Clinical Trials Directory

Trials / Unknown

UnknownNCT03627910

Pressure Ulcers in Patients Receiving Enteral Nutrition Therapy and Their Relationship With Gut Microbiota

Pressure Ulcers in Patients Receiving Enteral Nutrition Therapy. What is the Relationship With Gut Microbiota?

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Fondazione Don Carlo Gnocchi Onlus · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Participants will be randomly assigned to the experimental group where they will be given enteral nutrition formula rich in zinc and arginine plus a symbiotic (Probinul- Ca.Di.GROUP S.r.l.) once a day for 90 days or the control group where they will receive only the enteral nutrition formula rich in zinc and arginine.

Detailed description

Participants belonging to both experimental and control group will be evaluated at admission (T0), 45 days after admission (T45) and at the end of the study (T90, 90 days after admission). At each time point patients' nutritional status will be determined and the following biochemical parameters will be investigated: lymphocyte count, total proteins, protidogram, prealbumin, transferrin, vascular endothelial growth factor (VEGF), Platelet-derived growth factor (PDGF), beta transforming growth factor (TGF-beta). Analysis of fecal DNA will be also performed to characterize the gut microbiota. In addition, at the baseline and at T45 participants will be administered the Braden scale for predicting pressure sore risk.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTsymbioticFeed supplementation
DIETARY_SUPPLEMENTzinc and arginineFeed supplementation

Timeline

Start date
2017-06-11
Primary completion
2021-06-30
Completion
2022-01-31
First posted
2018-08-14
Last updated
2021-02-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03627910. Inclusion in this directory is not an endorsement.

Pressure Ulcers in Patients Receiving Enteral Nutrition Therapy and Their Relationship With Gut Microbiota (NCT03627910) · Clinical Trials Directory